SOHO 3rd Italian Conference

 

SOHO 3rd Italian Conference
Avatar

SOHO Italy 2021 on the Future of FLT3i in AML: Moving Towards a Cure

By SOHO 3rd Italian Conference FEATURING Giovanni Martinelli
By SOHO 3rd Italian Conference FEATURING Giovanni Martinelli
210 views
January 5, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Leukemia
14:52
SOHO 3rd Italian Conference

SOHO Italy 2021: Asciminib and the Need for New TKIs in CML

Feat. G. Saglio
16:38
SOHO 3rd Italian Conference

SOHO Italy 2021: New Perspectives of Maintenance Therapy in AML Mana…

Feat. F. Ravandi
10:59
SOHO 3rd Italian Conference

SOHO Italy 2021 on Asparaginase: Understanding and Overcoming Toxici…

Feat. C. Papayannidis
10:38
SOHO 3rd Italian Conference

SOHO Italy 2021 on ALL Management in Europe

Feat. G. Martinelli
12:07
SOHO 3rd Italian Conference

SOHO Italy 2021 on the Future of FLT3i in AML: Moving Towards a Cure

Feat. G. Martinelli
11:32
SOHO 3rd Italian Conference

SOHO Italy 2021: Chemotherapy Free Regimens in Ph+ ALL

Feat. S. Chiaretti
16:56
SOHO 3rd Italian Conference

SOHO Italy 2021: Becoming Pregnant on TKIs for CML - Current Managem…

Feat. E. Abruzzese
10:25
SOHO 3rd Italian Conference

SOHO Italy 2021: Full or Partial Treatment-Free Remission in CML

Feat. M. Malagola
12:46
SOHO 3rd Italian Conference

SOHO Italy 2021: CIK in Acute Leukemia

Feat. F. Lussana
14:17
SOHO 3rd Italian Conference

SOHO Italy 2021 Update on Elderly AML: Room for Improvement

Feat. A. Isidori
12:03
SOHO 3rd Italian Conference

SOHO Italy 2021: Modeling and Targeting of Erythroleukemia by Hemato…

Feat. I. Iacobucci
11:33
SOHO 3rd Italian Conference

SOHO Italy 2021: Pro-Apoptotic Pathways in AML

Feat. S. Galimberti
13:15
SOHO 3rd Italian Conference

SOHO Italy 2021 on Triple Negative ALL: Past, Present, and Future

Feat. A. Ferrari
17:01
SOHO 3rd Italian Conference

SOHO Italy 2021 on State of the Art of CLL Treatment in the USA

Feat. A. Ferrajoli
14:47
SOHO 3rd Italian Conference

SOHO Italy 2021 on IDHm AML: Beyond Enasidenib and Ivosidenib Monoth…

Feat. C. DiNardo
12:45
SOHO 3rd Italian Conference

SOHO Italy 2021: Emerging Targeted Therapies and Combinations for AML

Feat. N. Daver
20:41
SOHO 3rd Italian Conference

SOHO Italy 2021: Mechanisms of Resistance to FLT3i and Novel Combina…

Feat. N. Daver
13:20
SOHO 3rd Italian Conference

SOHO Italy 2021: Immune-Based and Novel Therapies in AML

Feat. N. Daver
18:37
SOHO 3rd Italian Conference

SOHO Italy 2021 Updates on Immunotherapy and TP53-Mutated AML: New H…

Feat. N. Daver
12:25
SOHO 3rd Italian Conference

SOHO Italy 2021 on State of the Art in CML Treatment in Italy

Feat. A. Cuneo
11:03
SOHO 3rd Italian Conference

SOHO Italy 2021: Drug Resistance in AML

Feat. C. Cerchione
15:10
SOHO 3rd Italian Conference

SOHO Italy 2021: Blastic Plasmacytoid Dendritic Cell Neoplasm in Ita…

Feat. E. Angelucci
11:48
SOHO 3rd Italian Conference

SOHO Italy 2021: CPX-351 in Secondary AML

Feat. A. Curti
13:13
SOHO 3rd Italian Conference

SOHO Italy 2021 Update on NK Cells in AML: Where We Stand

Feat. A. Curti